Palatin receives NYSE American delisting notice for equity deficiency; cure period extended to April 2025

PALATIN TECHNOLOGIES INC

NYSE American notified Palatin of non-compliance with Section 1003(a)(iii) requiring stockholders' equity of at least $6M after five consecutive years of losses.
Palatin was already non-compliant under Sections 1003(a)(i) and (ii); the new notice adds a third deficiency.
The Exchange accepted Palatin's compliance plan and granted a cure period through April 10, 2025, with quarterly monitoring.
The notice has no immediate effect on trading of PTN common stock, but failure to regain compliance could lead to delisting.
Palatin is exploring multiple funding avenues to achieve compliance and plans future transactions.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.